203 filings
Page 7 of 11
8-K
ejlypne 2wgthqkr
25 Mar 20
Evofem Biosciences Adopts Shareholder Rights Agreement
5:00pm
8-K
3gmn b7o2t
12 Mar 20
Evofem Biosciences Reports Fourth Quarter and Year-end 2019
8:00am
8-K
m8pks
26 Feb 20
Evofem Biosciences Appoints Former FDA Division Director Lisa Rarick, M.D., to its Board of Directors
8:30am
8-K
5k9ei 83v6gmpyx8
10 Jan 20
Regulation FD Disclosure
4:06pm
8-K
0zvn7eoczhw
16 Dec 19
Departure of Directors or Certain Officers
4:35pm
8-K
br28z f9tsh
2 Dec 19
Other Events
6:50am
8-K
ppgj04chxh4 3r
26 Nov 19
Other Events
7:30am
8-K
7dqdbxqe911q9fuu7gt6
6 Nov 19
Evofem Biosciences Reports Third Quarter 2019
4:06pm
8-K
2jn 4gpu3f
11 Oct 19
Entry into a Material Definitive Agreement
4:29pm
8-K
3vjdefdskyxpsw1creuc
4 Sep 19
Regulation FD Disclosure
9:07am
8-K
ibwgyqatgl0dgeq
5 Aug 19
Evofem Biosciences Reports Second Quarter 2019
4:11pm
8-K
24twaiz3rjl vbn34ab
10 Jun 19
Evofem Biosciences Closes $80 Million Financing Transaction
4:01pm
8-K
ekets8g vvi8ou5xlul
5 Jun 19
Departure of Directors or Certain Officers
5:07pm
8-K
dts4d7ukfnpk4ytj lmw
7 May 19
Evofem Biosciences Reports First Quarter 2019
6:13am
8-K
aytyld8eljjkyf2dnl
11 Apr 19
Closes First Tranche of Strategic Investment from PDL BioPharma
5:16pm
8-K
978gp6ig93zv3clvmhtj
1 Mar 19
Evofem Biosciences Reports Fourth Quarter and Year-End 2018
12:00am
8-K
q8l3whxu9ebsru30i
11 Feb 19
Entry into a Material Definitive Agreement
4:12pm
8-K
r03wl5i5 f099
7 Jan 19
Regulation FD Disclosure
6:11am
8-K
t7sfgnej
3 Jan 19
Evofem Biosciences Provides Corporate Update and Announces Upcoming Milestones
8:00am
8-K
5bhr55hm5lz8 h6d
17 Dec 18
Evofem Biosciences Announces Positive Top-Line Results of Phase 3 Study
6:05am